United Capital Financial Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

United Capital Financial Advisors’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50,000	Closed	-$18K	–	1357
2016 Q3	$18K	Hold	50,000	–	–	﹤0.01%	1248
2016 Q2	$0	Buy	+50,000	New	–	﹤0.01%	1323

United Capital Financial Advisors's RXII Position: Q4 2016 in Review

United Capital Financial Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 50,000 shares — an estimated $18K sold.

United Capital Financial Advisors first reported a position in RXII in Q2 2016 and held it in 2 quarters. The position peaked at $18K in Q3 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

United Capital Financial Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
United Capital Financial Advisors sold 50,000 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $18K.
United Capital Financial Advisors first reported a position in GALENA BIOPHARMA INC COM in Q2 2016 and held it in 2 quarters.
United Capital Financial Advisors's GALENA BIOPHARMA INC COM position peaked at $18K in Q3 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on United Capital Financial Advisors's 13F filing for Q4 2016, filed 15 Feb 2017.